Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Platform Partners: $180 Million Of Follow-On Equity Capital Commitments Raised | ||
Fr | Centivo: Jim McNary Named As President And Chief Operating Officer | ||
Fr | Bioptimus: $76 Million In Total Funding Raised By AI Foundation Company | ||
Fr | Workwize: $13 Million (Series A) Raised To Transform IT Asset Management | ||
Fr | Teal Health: $10 Million (Seed) Closed To Launch Wand For At-Home Cervical Cancer Screening | ||
Fr | Micron Biomedical: Series A Funding Extended To Over $33 Million | ||
Fr | Janus Henderson: Kelly Cavagnaro Named As Head Of North America Institutional | ||
Fr | Schwab Asset Management Launching The Schwab Core Bond ETF | ||
Fr | Kiteworks: 2025 Cybersecurity Report Highlights Risks And Strategies For Content Protection | ||
Fr | Ashvattha: $50 Million (Series B Extension) Raised For Developing Nanomedicine Therapeutics | ||
Fr | Apollo Commercial Real Estate Finance: $1.9 Billion In Loan Originations For 2024 | ||
Fr | HT Materials Science: Interview With CEO Thomas Grizzetti About The Heat Transfer Fluid Company | ||
Fr | UAV: $105 Million In Sales Contract LOIs Secured For Dart Series Airships | ||
Fr | SuperDial Buying MajorBoost For Expanding Voice AI Capabilities | ||
Fr | NV5 To Buy Infrastructure Engineering Provider Group Delta | ||
Fr | Apollo To Buy Argo Infrastructure Partners, Adding $6 Billion Of Assets | ||
Fr | Kratos: Hypersonic System Program Award Received With Potential Value Of About $100 Million | ||
Fr | Act III Holdings: Strategic Investment In Honest Greens Barcelona | ||
Fr | DTE Energy: $3.3 Billion Spent With Michigan Suppliers In 2024 | ||
Do | Advisor360° Buys GenAI Provider Company Parrot AI | ||
Do | Sidley Brings In M&A Partners David Grubman And Adam Cromie To New York Office | ||
Do | Enable Buying Pricing Engine Company Flintfox | ||
Do | Zellis Buying HR Software Company elementsuite | ||
Do | Holly: $2.2 Million Raised To Modernize Government Hiring | ||
Do | Ouro Medicines: $120 Million Raised For Developing Immune Reset Therapeutics |